NCT01892930View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 11, 2013

Primary Completion Date

December 30, 2015

Study Completion Date

December 30, 2016

Conditions
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
Interventions
RADIATION

stereotactic body radiation therapy

Undergo SBRT

PROCEDURE

therapeutic conventional surgery

Undergo partial or radical nephrectomy

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT01892930 - Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter